Our studies were focused on the Cjoc42-mediated change of Gank activities toward tumor suppressors; however, Gank also affects several additional pathways of liver cancer including NF-kB pathway (Li et al., 2018), β-catenin pathway (He et al., 2016; Liu et al., 2019). Here, NFKB1 is linked to liver cancer.